Company news
Tty Biopharm Company Limited (TPEX:4105) news
Tty Biopharm Company Limited news releases on 6ix. Latest, Aug 11, 2022: TTY Biopharm : Announcement of TTY Biopharm's unaudited income information in July 2022
Press releases & updates
TTY Biopharm : Announcement of TTY Biopharm's unaudited income information in July 2022
August 11, 2022
TTY Biopharm : Announcement of the consolidated financial report for the second quarter of year 2022
August 5, 2022
TTY Biopharm : Announcement of TTY Biopharm's unaudited income information in June 2022
July 11, 2022
TTY Biopharm : Announcement of the record date of cash dividend.
July 1, 2022
TTY Biopharm : Announcement of TTY Biopharm's unaudited income information in May 2022
June 13, 2022
TTY Biopharm : To announce the Company received milestone from global pharmaceutical company for co-development overseas market of long-lasting microsphere drug.
May 26, 2022
TTY Biopharm : Important resolutions of the Company's 2022 Annual General Meeting
May 26, 2022
TTY Biopharm : Announcement of TTY Biopharm's unaudited income information in Mar 2022
April 13, 2022
TTY Biopharm : Announcement of TTY Biopharm's committee member of Remuneration committee resignation
March 31, 2022
TTY Biopharm : Announcement of TTY Biopharm's unaudited income information in Feb 2022
March 11, 2022
TTY Biopharm : Announcement of Year 2022 Annual General Meeting
March 9, 2022
TTY Biopharm : To announce the change of General Manager
March 9, 2022
TTY Biopharm : Board of Directors proposed dividend distribution
March 9, 2022
TTY Biopharm : Announcement of the financial report for the year of 2021
March 9, 2022
TTY : Biopharm Co Ltd. - TS-1 Capsule received TW NHI approval for Treatment of Patients with Locally Advanced or Metastatic Non-small Cell Lung Cancer
February 3, 2020